Genetic Study of Young Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
- Status
- COMPLETED
- Phase
- PHASE2
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
- Status
- COMPLETED
- Phase
- PHASE3
CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
- Status
- COMPLETED
- Phase
- PHASE2
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
- Status
- UNKNOWN
- Phase
- NA
BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps
- Status
- COMPLETED
- Phase
- PHASE3